Fiche centre
Arthritis & Rheumatic Disease Specialties
Aventura — United States
Essais liés5clinical trials
VilleAventuralocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04539964
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System | SEP | Non applicable | NCT03437473 | Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) | COMPLETED |
| SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System | SEP | Non applicable | NCT04862117 | Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) | ACTIVE_NOT_RECRUITING |
| Implant Procedure | SEP | Phase 3 | NCT04539964 | RESET-RA — Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis | ACTIVE_NOT_RECRUITING |
| Nipocalimab | Lupus | Phase 3 | NCT07438496 | GARDENIA-SLE — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | RECRUITING |
| Litifilimab | Lupus | Phase 3 | NCT05352919 | EMERALD — An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus | ENROLLING_BY_INVITATION |